Protagonist Therapeutics (PTGX)

• Market cap: $5.38B
• 1 day: 1.93%
• 5 days: 1.39%
• 1 month: 12.12%
• 3 months: 52.92%
• 6 months: 88.76%
• Year to date: 120.68%
• 1 year: 122.56%
• 5 years: 300.09%
• 10 years: 635.21%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Employees: 128